
European Journal of Medicinal Chemistry p. 399 - 420 (1998)
Update date:2022-08-05
Topics:
Leonardi, Amedeo
Motta, Gianni
Pennini, Renzo
Testa, Rodolfo
Sironi, Giorgio
Catto, Alberto
Cerri, Alberto
Zappa, Marco
Bianchi, Giorgio
Nardi, Dante
A series of asymmetric 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates characterized by the presence of a 3,3-diphenylpropylamino moiety in one of the ester groups were synthesized. They exhibited remarkable antihypertensive activity in spontaneously hypertensive rats as well as affinity for the 1,4- dihydropyridines binding site labelled by 3H-nitrendipine in the calcium channel. Introduction of this bulky and lipophilic amine confers to the whole series an elevated level of antihypertensive activity and a long duration of action, a structure-dependent modulation of the activity being found only in the subset characterized by the presence of a branched propylene bridge between the ester and the amino groups. The presence of the amino group is essential for oral activity. Out of this series, compound 9u (Rec 15/2375- lercanidipine) was selected for clinical development and obtained marketing authorization as an antihypertensive in several countries.
View MoreTaizhou Crene Biotechnology co.ltd
Contact:86-576-88813233 88205808
Address:Economic Developed Zone of Taizhou Zhejiang China
Antaeus Bio-technology Co., LTD(expird)
Contact:021-31252569
Address:shanghai pudong
Xinjiang Zhongtai Chemical Co., Ltd.
Contact:+86-991-8788172
Address:NO.78 XISHAN RD.URUMQI,CHINA
Contact:+(852) 301-98033
Address:Flat C, 23/F, Lucky Plaza, 315-321 Lockhart Road, Wan Chai, Hong Kong
NEW FORTUNE INDUSTRIAL CO.,LTD.
website:http://newfortune.lookchem.com/
Contact:+86-25-8645-9456
Address:C4-105 GREEN ISLAND FLOWER TOWN
Doi:10.1007/s11178-006-0034-8
(2005)Doi:10.1021/jm00117a013
(1988)Doi:10.1016/0022-328X(85)80069-3
(1985)Doi:10.1016/j.bmc.2007.11.060
(2008)Doi:10.1016/S0040-4020(01)96638-4
(1985)Doi:10.1021/jm901771h
(2010)